Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management
暂无分享,去创建一个
[1] N. Barrett. Chronic peptic ulcerz of the œophagus and ‘œsophagitis’ , 1950 .
[2] N R BARRETT,et al. Chronic peptic ulcer of the oesophagus and 'oesophagitis'. , 1950, The British journal of surgery.
[3] P. Allison,et al. The Oesophagus Lined with Gastric Mucous Membrane , 1953, Thorax.
[4] N R BARRETT,et al. The lower esophagus lined by columnar epithelium. , 1957, Surgery.
[5] Barrett's epithelium complicating lye ingestion with sparing of the distal esophagus. , 1981, Gastroenterology.
[6] R C Heading,et al. Barrett's oesophagus. , 1987, British medical journal.
[7] M. Indelli,et al. Barrett esophagus after chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF): an iatrogenic injury? , 1991, Annals of internal medicine.
[8] J R Bennett,et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. , 1996, Gastroenterology.
[9] O. Cummings,et al. Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. , 1999, Gastrointestinal endoscopy.
[10] R. Lord,et al. Norman Barrett, "doyen of esophageal surgery". , 1999, Annals of surgery.
[11] Patricia L. Blount,et al. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia , 2000, American Journal of Gastroenterology.
[12] P. Dítě,et al. [Barrett's esophagus]. , 2000, Bratislavske lekarske listy.
[13] R. Sandler,et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? , 2000, Gastroenterology.
[14] Gary Longton,et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets , 2000, American Journal of Gastroenterology.
[15] Prateek Sharma,et al. Long-term follow-up of Barrett's high-grade dysplasia , 2000, American Journal of Gastroenterology.
[16] A. Csendes,et al. Early and late results of the acid suppression and duodenal diversion operation in patients with Barrett’s esophagus: Analysis of 210 cases , 2002, World Journal of Surgery.
[17] E. Montgomery,et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. , 2001, Human pathology.
[18] A. Sonnenberg,et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.
[19] J. Rees,et al. Treatment for Barrett's oesophagus. , 2002, The Cochrane database of systematic reviews.
[20] L. Gossner,et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach , 2002, European journal of gastroenterology & hepatology.
[21] P. Parrilla,et al. Barrett’s Esophagus Without Esophageal Stricture Does Not Increase the Rate of Failure of Nissen Fundoplication , 2003, Annals of surgery.
[22] N. Vakil,et al. Clinical effectiveness of laparoscopic fundoplication in a U.S. community. , 2003, The American journal of medicine.
[23] K. Kerlikowske,et al. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. , 2003, Gastroenterology.
[24] J. Lagergren,et al. T helper cell polarisation in coeliac disease: any (T-)bet ? , 2004, Gut.
[25] Bergein F Overholt,et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.
[26] T. Lerut,et al. Quality in the surgical treatment of cancer of the esophagus and gastroesophageal junction. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[27] Michael Vieth,et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. , 2005, Gastroenterology.
[28] N. Shaheen. Does Fundoplication Change the Risk of Esophageal Cancer in the Setting of GERD? , 2005, The American Journal of Gastroenterology.
[29] L. Gossner,et al. Curative treatment for high-grade intraepithelial neoplasia in Barrett's esophagus. , 2005, Endoscopy.
[30] R. Fitzgerald,et al. Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[31] Andrea May,et al. The Impact of Endoscopic Ultrasound and Computed Tomography on the TNM Staging of Early Cancer in Barrett's Esophagus , 2006, The American Journal of Gastroenterology.
[32] E. Montgomery,et al. Management of high-grade dysplasia in patients with Barrett's esophagus. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[33] J. Dent,et al. The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus , 2006, The American Journal of Gastroenterology.
[34] A. Csendes,et al. Very Late Results of Esophagomyotomy for Patients With Achalasia: Clinical, Endoscopic, Histologic, Manometric, and Acid Reflux Studies in 67 Patients for a Mean Follow-up of 190 Months , 2006, Annals of surgery.
[35] J. Dent,et al. Review article: from 1906 to 2006 – a century of major evolution of understanding of gastro‐oesophageal reflux disease , 2006, Alimentary pharmacology & therapeutics.
[36] Michael Vieth,et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. , 2006, Gastroenterology.
[37] L. Gossner,et al. Prospective evaluation of the macroscopic types and location of early Barrett's neoplasia in 380 lesions. , 2007, Endoscopy.
[38] M. Vieth,et al. Low-grade dysplasia in Barrett’s esophagus - an innocent bystander? Contra , 2007, Endoscopy.
[39] J. Bergman. Endoscopic resection for treatment of mucosal Barrett's cancer: time to swing the pendulum. , 2007, Gastrointestinal endoscopy.
[40] D. Treanor,et al. Low-grade dysplasia in Barrett's esophagus has a high risk of progression , 2007, Endoscopy.
[41] J. Hunter,et al. The Effect of Antireflux Surgery on Esophageal Carcinogenesis in Patients With Barrett Esophagus: A Systematic Review , 2007, Annals of surgery.
[42] Michael Vieth,et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). , 2005, Gastrointestinal endoscopy.
[43] C. Maley. Open questions in oesophageal adenocarcinogenesis , 2007, Gut.
[44] A. Shar,et al. Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial. , 2007, Journal of the National Cancer Institute.
[45] T. Stephenson,et al. Barrett's oesophagus: Intestinal metaplasia is not essential for cancer risk , 2007, Scandinavian journal of gastroenterology.
[46] N. Buttar,et al. Chemoprevention in Barrett’s Esophagus , 2007, Journal of gastrointestinal cancer.
[47] Keith Abrams,et al. Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies , 2007, The American Journal of Gastroenterology.
[48] V. Konda,et al. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[49] M. Vieth,et al. Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett’s oesophagus , 2008, Gut.
[50] N. Nishioka,et al. Treatment of Barrett's esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[51] H. El‐Serag. The Association Between Obesity and GERD: A Review of the Epidemiological Evidence , 2008, Digestive Diseases and Sciences.
[52] Wouter L Curvers,et al. Multimodality imaging in Barrett's esophagus: looking longer, seeing better, and recognizing more. , 2008, Gastroenterology.
[53] Michael B Wallace,et al. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus. , 2008, Gastroenterology.
[54] Wei-Chih Liao,et al. Prevalence and Clinical Characteristics of Barrett's Esophagus in a Chinese General Population , 2008, Journal of clinical gastroenterology.
[55] C. Ell,et al. Medical or Surgical Management of GERD Patients with Barrett’s Esophagus: The LOTUS Trial 3-Year Experience , 2008, Journal of Gastrointestinal Surgery.
[56] H. El‐Serag,et al. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. , 2008, Gastrointestinal endoscopy.
[57] Kenneth J. Chang,et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. , 2008, Gastrointestinal endoscopy.
[58] P. Moayyedi,et al. Management of Barrett's Esophagus in the UK: Overtreated and Underbiopsied but Improved by the Introduction of a National Randomized Trial , 2008, The American Journal of Gastroenterology.
[59] L. Gossner,et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus , 2008, Gut.
[60] E. Montgomery. Refining diagnostic criteria for high-grade dysplasia in Barrett esophagus. , 2009, American journal of clinical pathology.
[61] O. Pech. Declaration of bankruptcy for four-quadrant biopsies in Barrett's esophagus? , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[62] V. Konda,et al. Complete Barrett's Eradication Endoscopic Mucosal Resection: An Effective Treatment Modality for High-Grade Dysplasia and Intramucosal Carcinoma—An American Single-Center Experience , 2008, The American Journal of Gastroenterology.
[63] M. Winslet,et al. Aspirin is not chemoprotective for Barrett's adenocarcinoma of the oesophagus in multicentre cohort , 2009, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[64] S. Peng,et al. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population. , 2009, Endoscopy.
[65] N. Shaheen,et al. Association of adiponectin multimers with Barrett’s oesophagus , 2009, Gut.
[66] M. Vieth,et al. Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. , 2009, Human pathology.
[67] R. Goyal,et al. Metaplastic Esophageal Columnar Epithelium Without Goblet Cells Shows DNA Content Abnormalities Similar to Goblet Cell–Containing Epithelium , 2009, The American Journal of Gastroenterology.
[68] Radiofrequency ablation of Barrett's esophagus: should everybody get it? , 2009, Gastroenterology.
[69] Prateek Sharma,et al. Clinical practice. Barrett's esophagus. , 2009, The New England journal of medicine.
[70] G. Lyratzopoulos,et al. Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review. , 2009, Gastroenterology.
[71] Aanand D. Naik,et al. Surveillance in Barrett's esophagus: lessons from behavioral economics. , 2009, Gastroenterology.
[72] F. Islami,et al. Use of Proton Pump Inhibitors and Risk of Progression of Barrett's Esophagus to Neoplastic Lesions , 2009, The American Journal of Gastroenterology.
[73] Kenneth K Wang,et al. Management of Nondysplastic Barrett's Esophagus: Where Are We Now? , 2009, The American Journal of Gastroenterology.
[74] Hiroshi Mashimo,et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. , 2009, The New England journal of medicine.
[75] R. Odze,et al. Endoscopic Variceal Band Ligation , 2009, The American Journal of Gastroenterology.
[76] R. Odze,et al. Definition of Barrett's Esophagus: Time for a Rethink—Is Intestinal Metaplasia Dead? , 2009, The American Journal of Gastroenterology.
[77] M. Orringer,et al. A histologically defined subset of high-grade dysplasia in Barrett mucosa is predictive of associated carcinoma. , 2009, American journal of clinical pathology.
[78] Ji Won Kim,et al. The Prevalence of and Risk Factors for Barrett's Esophagus in a Korean Population: A Nationwide Multicenter Prospective Study , 2009, Journal of clinical gastroenterology.
[79] N. Shaheen,et al. A cost-utility analysis of ablative therapy for Barrett's esophagus. , 2009, Gastroenterology.
[80] A. Rastogi,et al. Esophageal Adenocarcinoma in Barrett's Esophagus After Endoscopic Ablative Therapy: A Meta-Analysis and Systematic Review , 2009, The American Journal of Gastroenterology.
[81] Clinical characteristics of gastroesophageal reflux disease in Japan. , 2009, Hepato-gastroenterology.
[82] M. Vieth,et al. Differences in the Definitions Used for Esophageal and Gastric Diseases in Different Countries , 2009, Digestion.
[83] Study Outlines Strategies to Test New Payment Models for Health Care , 2009 .
[84] Revital Kariv,et al. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[85] M. O’Donovan,et al. Non-endoscopic screening biomarkers for Barrett’s oesophagus: from microarray analysis to the clinic , 2009, Gut.
[86] Kenneth K. Wang,et al. Predictors of Progression in Barrett's Esophagus: Current Knowledge and Future Directions , 2010, The American Journal of Gastroenterology.
[87] M. Bourke,et al. Endoscopic Resection for Barrett's High-Grade Dysplasia and Early Esophageal Adenocarcinoma: An Essential Staging Procedure With Long-Term Therapeutic Benefit , 2010, The American Journal of Gastroenterology.
[88] L. Murray,et al. A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence. , 2010, Gastroenterology.
[89] J. Dent,et al. The effects of high‐dose esomeprazole on gastric and oesophageal acid exposure and molecular markers in Barrett’s oesophagus , 2010, Alimentary pharmacology & therapeutics.
[90] G. Meijer,et al. Low-Grade Dysplasia in Barrett's Esophagus: Overdiagnosed and Underestimated , 2010, The American Journal of Gastroenterology.
[91] B. Reid,et al. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis , 2010, Nature Reviews Cancer.
[92] Kenneth K Wang,et al. History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. , 2010, Gastroenterology.
[93] K. Behrns. Endoscopic and Surgical Treatment of Mucosal (T1a) Esophageal Adenocarcinoma in Barrett's Esophagus , 2010 .
[94] J. Lagergren,et al. The risk of esophageal adenocarcinoma after antireflux surgery. , 2010, Gastroenterology.
[95] Alexander Meining,et al. Preliminary accuracy and interobserver agreement for the detection of intraepithelial neoplasia in Barrett's esophagus with probe-based confocal laser endomicroscopy. , 2010, Gastrointestinal endoscopy.
[96] J. Emery,et al. Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study , 2010, BMJ : British Medical Journal.
[97] E. El-Omar,et al. Interobserver reliability in the endoscopic diagnosis and grading of Barrett's esophagus: an Asian multinational study. , 2010, Endoscopy.
[98] E. Kuipers,et al. Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[99] N. Shaheen. Risk and reason in Barrett's esophagus. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[100] Kenneth K Wang,et al. Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[101] Peter J. Richardson,et al. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. , 2010, Gastroenterology.
[102] G. Triadafilopoulos. Blitzkrieg for barrett's esophagus containing early neoplasia. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[103] Thomas D. Wang,et al. Affinity peptide for targeted detection of dysplasia in Barrett's esophagus. , 2010, Gastroenterology.
[104] Hirokazu Takahashi,et al. Shape of Barrett's epithelium is associated with prevalence of erosive esophagitis. , 2010, World journal of gastroenterology.
[105] S. Spechler,et al. Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus. , 2010, Gastroenterology.
[106] J. Dent,et al. Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: The systematic investigation of gastrointestinal diseases in China (SILC) , 2011, Scandinavian journal of gastroenterology.